Private Equity Firm Other

THL Partners

Boston, Massachusetts, United States

THL Partners is a Boston-based private equity firm investing in middle-market growth companies across Financial Technology & Services, Healthcare, and Technology & Business Solutions. The firm partners with management teams and uses internal operating resources to transform and build companies of lasting value.

Focus Areas
Financial Technology & Services, Healthcare, Technology & Business Solutions
Website
thl.com

Tracked deals

17

17 tracked deals across 2013-2026.

Recent pace

2

2 tracked deals announced in the last 12 months.

Deal mix

Buyout

7 buyout · 5 growth capital · 3 recapitalization

THL Partners Acquisition Volume by Year

Last 7 years

Acquisition volume by year Annual acquisition counts for the last 7 years for THL Partners. 2 2019 1 2020 3 2021 4 2022 1 2023 3 2024 ~3 est. 2 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

Showing the 12 most recent of 17 tracked deals for THL Partners.

  • Buyer
    THL Partners
    Target
    Queue-it
    Seller
    GRO
    Industry
    Cybersecurity
    Location
    Denmark

    Queue-it entered a definitive agreement for THL Partners to make a majority investment in the company. The partnership is intended to accelerate product innovation and expand Queue-it’s global reach for its online traffic orchestration platform.

  • Buyer
    THL Partners, H.I.G. Capital (seller)
    Target
    Celerion Holdings, Inc., Celerion
    Seller
    H.I.G. Capital (via affiliates)
    Type
    Buyout

    THL Partners is acquiring a majority stake in Celerion Holdings, Inc. for approximately $1.8 billion from funds affiliated with H.I.G. Capital. The deal is focused on advancing Celerion’s clinical pharmacology and bioanalytical capabilities, with completion expected in 2026 subject to customary conditions and regulatory approval.

  • Buyer
    THL Partners (Thomas H. Lee Partners)
    Target
    Red Nucleus
    Seller
    The Riverside Company (Riverside), Riverside Capital Appreciation strategy (RCAF)
    Type
    Buyout

    THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.

  • Buyer
    THL Partners
    Target
    AMI
    Seller
    HGGC
    Industry
    Software
    Type
    Buyout

    THL Partners has agreed to acquire a majority stake in AMI from HGGC in a private transaction expected to close in fall/Q4 2024. AMI, headquartered in Duluth, Georgia, is a global leader in dynamic firmware used across data centers and cloud platforms and employs over 1,500 engineers; THL says the investment will accelerate product innovation and market expansion to address growing AI and hyperscale infrastructure demand.

  • Buyer
    THL Partners
    Target
    YA Group
    Seller
    CIVC Partners

    THL Partners has agreed to make a majority investment in YA Group, a Nashville-based professional services firm providing forensic consulting, engineering, and risk mitigation services to insurance and public-sector clients. Current investor CIVC Partners, management and employees will retain significant ownership, and the capital will be used to accelerate organic growth, expand core capabilities and pursue strategic acquisitions.

  • Buyer
    Smile Doctors, Linden Capital Partners, Thomas H. Lee Partners
    Target
    Grinz Orthodontics
    Seller
    Grinz Orthodontics, Dr. Richard Ziehmer
    Industry
    Dental
    Type
    Addon

    Smile Doctors, a PE-backed orthodontic support organization, has acquired Grinz Orthodontics. The deal adds Grinz's practices in North Carolina and Arizona to Smile Doctors' network; Smile Doctors is a portfolio company of Linden Capital Partners and Thomas H. Lee Partners.

  • Buyer
    Thomas H. Lee Partners
    Target
    Carpe Data
    Seller
    Founders and management, Existing strategic investors
    Industry
    Data & Analytics

    Thomas H. Lee Partners (THL) has made a strategic growth investment in Carpe Data, becoming the majority shareholder while the company's founders, management and existing strategic investors retain meaningful stakes. The investment will fund continued innovation in Carpe Data's AI-driven alternative data platform for insurance and support expansion across core segments and adjacent markets.

  • Buyer
    Thomas H. Lee Partners
    Target
    Intelligent Medical Objects
    Seller
    Warburg Pincus
    Type
    Buyout

    Thomas H. Lee Partners (THL) has agreed to acquire a majority interest in Intelligent Medical Objects (IMO) from Warburg Pincus. THL's investment will support IMO's product development and expansion of commercial relationships with hospitals, physicians and other healthcare organizations.

  • Buyer
    Thomas H. Lee Partners, Premier, Inc., ThedaCare, Bessemer Venture Partners, Mayfield, Norwest Venture Partners
    Target
    Qventus, Inc.

    Qventus announced a $50 million growth capital round led by Thomas H. Lee Partners with a strategic partnership and investment from Premier, Inc.; ThedaCare and existing investors Bessemer Venture Partners, Mayfield, and Norwest Venture Partners also participated. The funding and partnership will help Qventus expand its AI-powered care-operations platform across additional hospitals and health systems and enable product enhancements that leverage Premier’s data assets.

  • Buyer
    Thomas H. Lee Partners, Linden Capital Partners
    Target
    Smile Doctors

    Smile Doctors, the largest U.S. orthodontics-focused dental support organization with more than 295 locations, announced a strategic investment from Thomas H. Lee Partners. THL is investing alongside existing sponsor Linden Capital Partners in an equal partnership while affiliated orthodontists retain a significant ownership stake to support continued growth and expanded service offerings.

  • Buyer
    Adare Pharma Solutions, Thomas H. Lee Partners, Frazier Healthcare Partners
    Target
    Frontida BioPharm
    Industry
    Pharmaceuticals
    Type
    Addon

    Adare Pharma Solutions, a PE-backed contract development and manufacturing organization (CDMO), has acquired Frontida BioPharm, a vertically integrated CDMO focused on oral formulations. The deal expands Adare’s capabilities—including high-potency compound handling and packaging services—and increases its manufacturing footprint; Adare is backed by Thomas H. Lee Partners and Frazier Healthcare Partners.

  • Buyer
    Thomas H. Lee Partners
    Target
    Odessa
    Industry
    Software

    Thomas H. Lee Partners (THL) has made a strategic growth investment in Odessa, a Philadelphia-based provider of asset finance and leasing software. The investment will fund Odessa's platform roadmap, capability expansion across financial services, geographic growth (U.S. and international), and potential M&A activity to accelerate product and market expansion.

Related Acquisition Pages

Selling a company? Get in front of buyers like THL Partners

Turn tracked acquisition activity into an outreach-ready buyer list.